Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

Authors: Jeffrey A Meyerhardt, Sunil Kumar, Jessica A Zerillo, Aparna Parikh, James M Cleary, Scott Rodig, Benjamin Schlechter, Kimmie Ng, Stephanie K Dougan, Nora Horick, Glenn J Hanna, Andrew L Coveler, Anuj K Patel, Nadine J McCleary, Douglas A Rubinson, Jeffrey W Clark, Kent Mouw, Kathleen Pfaff, Thomas A Abrams, Matthew B Yurgelun, Eliezer M Van Allen, S Jennifer Wang, Leah H Biller, Harshabad Singh, Emma L Welsh, Brandon M Huffman, Lestat R Ali, Megan T Hoffman, Katherine A Metayer, Shayla Murray, Alexandra Bird, Jennifer A Chan, Wolfram Goessling, Jeffrey S Wisch, Brendan Reardon, Robert J Mayer, Catherine Del Vecchio Fitz, Charlotte Kuperwasser

Source: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 1 (2024)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/12/1/e008436.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/3355b66d86a3433d9514838bcb4205a5

Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas

Authors: Thomas F Gajewski, John A Thompson, Sanjay Goel, Brendan D Curti, Elisabeth I Heath, Olivier Rixe, David C Smith, Celine Jacquemont, Tycel Phillips, Martin Gutierrez, Sahar Ansari, Andrew L Coveler, Svetomir N Markovic, Timothy M Kuzel, Amitkumar N Mehta, David L Bajor, Hun Ju Lee, Ajay K Gopal, Paolo Caimi, Ariel Topletz-Erickson, Peigen Zhou, Michael W Schmitt, Juneko E Grilley-Olson

Source: Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/11/6/e005584.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/997d45d0420040f2a6abbe4400763c7d

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates

Authors: Mary L Disis, John B Liao, Doreen M Higgins, Jennifer S Childs, Sasha E Stanton, Anna V Tinker, William R Gwin, Renata R Urban, Katie M Hitchcock-Bernhardt, Andrew L Coveler, Hania N Shakalia, Ron E Swensen, Tanya A Wahl, Richard G Ancheta, Kathryn F McGonigle, James Y Dai, Barbara A Goff

Source: Journal for ImmunoTherapy of Cancer, Vol 9, Iss 9 (2021)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/9/9/e003122.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/fa0344d0725b4c7788695fafcc3f18e8

A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer

Authors: William R. Gwin, Lupe G. Salazar, James Y. Dai, Doreen Higgins, Andrew L. Coveler, Jennifer S. Childs, Rosie Blancas, Yushe Dang, Jessica Reichow, Meredith Slota, Hailing Lu, Mary L. Disis

Source: Vaccines, Vol 13, Iss 2, p 117 (2025)

Subject Terms: denileukin diftitox, regulatory T-cells, breast cancer, immunity, tumor microenvironment, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/13/2/117; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/35d00e26ebb74b419a02cb575de57968

Leveraging patient‐reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience

Authors: Arjun Gupta, Omar Khalid, Cassadie Moravek, Anica Lamkin, Lynn M. Matrisian, Sudheer Doss, Crystal S. Denlinger, Andrew L. Coveler, Colin D. Weekes, Eric J. Roeland, Andrew E. Hendifar, Ryan D. Nipp

Source: Cancer Medicine, Vol 10, Iss 20, Pp 7152-7161 (2021)

Subject Terms: PanCAN, pancreatic cancer, patient‐reported outcomes, registry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://doaj.org/toc/2045-7634

Access URL: https://doaj.org/article/8e578e5119c14f258b24d714ce438ede

Multi-Epitope-Based Vaccines for Colon Cancer Treatment and Prevention

Authors: Lauren R. Corulli, Denise L. Cecil, Ekram Gad, Marlese Koehnlein, Andrew L. Coveler, Jennifer S. Childs, Ronald A. Lubet, Mary L. Disis

Source: Frontiers in Immunology, Vol 12 (2021)

Subject Terms: immunotherapy, colon cancer, CDC25B, COX2, IFN-gamma, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2021.729809/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/3015375de6f44692a214a513d19c7329

GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties

Authors: Robin Park, Andrew L. Coveler, Ludimila Cavalcante, Anwaar Saeed

Source: Biology, Vol 10, Iss 7, p 610 (2021)

Subject Terms: glycogen synthase kinase-3 beta, pancreatic ductal adenocarcinoma, immunotherapy, 9-ING-41, Biology (General), QH301-705.5

File Description: electronic resource

Relation: https://www.mdpi.com/2079-7737/10/7/610; https://doaj.org/toc/2079-7737

Access URL: https://doaj.org/article/6071325e0bf4464d909e040dd8a902b9